BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6531754)

  • 1. High fibrinopeptide A (FPA) levels in acute non-lymphocytic leukemia are reduced by heparin administration.
    Gugliotta L; Viganò S; D'Angelo A; Guarini A; Tura S; Mannucci PM
    Thromb Haemost; 1984 Dec; 52(3):301-4. PubMed ID: 6531754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
    Murakoshi T
    Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen survival and fibrinopeptide A in acute leukemia.
    Castaman G; Galloni E; Dri AV; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):52-6. PubMed ID: 8039760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Mombelli G; Monotti R; Haeberli A; Straub PW
    Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of plasma fibrinopeptide A (fpA) in patients with malignancy.
    Peuscher FW; Cleton FJ; Armstrong L; Stoepman-van Dalen EA; van Mourik JA; van Aken WG
    J Lab Clin Med; 1980 Jul; 96(1):5-14. PubMed ID: 7391657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus.
    Cronlund M; Hardin J; Burton J; Lee L; Haber E; Bloch KJ
    J Clin Invest; 1976 Jul; 58(1):142-51. PubMed ID: 932202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fibrinogen metabolism and plasma fibrinopeptide A in disseminated neoplasms].
    Mombelli G; Roux A; Hofmann V; Straub PW
    Schweiz Med Wochenschr; 1979 Dec; 109(47):1901. PubMed ID: 531571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
    Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
    J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of fibrinopeptide A in acute lymphocytic and non-lymphocytic leukaemia.
    Rodeghiero F; Castaman G; Soffiati G; Quaglio R; Castronovo S; Cortesi S; Dini E
    Blut; 1989 Aug; 59(2):177-83. PubMed ID: 2765677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinopeptide A (FPA) level and fibrinogen kinetics in patients with malignant disease.
    Yoda Y; Abe T
    Thromb Haemost; 1981 Dec; 46(4):706-9. PubMed ID: 7330820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Plasmodium falciparum malaria on plasma fibrinopeptide-A (FpA) concentration.
    Jimmy EO; Saliu I; Okpala I; Walker O; Sowumni A; Ademowo OG; Essien EM
    Cent Afr J Med; 1995 Apr; 41(4):124-7. PubMed ID: 7788683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of fibrinopeptide A in human blood.
    Nossel HL; Yudelman I; Canfield RE; Butler VP; Spanondis K; Wilner GD; Qureshi GD
    J Clin Invest; 1974 Jul; 54(1):43-53. PubMed ID: 4600045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of fibrinopeptide A in the evaluation of heparin activity and fibrin formation during hemodialysis.
    Wilhelmsson S; Asaba H; Gunnarsson B; Kudryk B; Robinson D; Bergström J
    Clin Nephrol; 1981 May; 15(5):252-8. PubMed ID: 7249422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 125I-fibrinogen kinetics and fibrinopeptide A in patients with disseminated neoplasias.
    Mombelli G; Roux A; Haeberli A; Straub PW
    Blood; 1982 Aug; 60(2):381-8. PubMed ID: 7093524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity.
    Nossel HL; Ti M; Kaplan KL; Spanondis K; Soland T; Butler VP
    J Clin Invest; 1976 Nov; 58(5):1136-44. PubMed ID: 993337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of thrombin generation to peripheral blast cell count in patients with acute myeloblastic leukemia (AML).
    Scharf RE; Schneider W
    Eur J Haematol; 1990 May; 44(5):273-6. PubMed ID: 2369938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of acute leukemia with disseminated intravascular coagulation in adults. Analysis of 14 cases].
    Zuazu I; Canals C; Sempere A; Martín S; Brunet S; Puig J; Fontcuberta J; Grau E
    Med Clin (Barc); 1989 Oct; 93(12):441-4. PubMed ID: 2607808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of fibrinopeptide A by high performance liquid chromatography and its significance.
    Mao P; Wang BM; Shen D; Wei WN
    Chin Med J (Engl); 1988 May; 101(5):353-6. PubMed ID: 3145836
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrinopeptide A in urine from patients with venous thromboembolism, disseminated intravascular coagulation and rheumatoid arthritis--evidence for dephosphorylation and carboxyterminal degradation of the peptide by the kidney.
    Leeksma OC; Meijer-Huizinga F; Stoepman-van Dalen EA; van Aken WG; van Mourik JA
    Thromb Haemost; 1985 Dec; 54(4):792-8. PubMed ID: 4089813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.